TrialThe lancet. HIV2020

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study.

Lindsey R Baden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.